Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Maurizio Salvadori & Elisabetta Bertoni. (2011) Long-term outcome of everolimus treatment in transplant patients. Transplant Research and Risk Management 3, pages 77-90.
Read now
Read now
Articles from other publishers (13)
Noelle K X Chung, Peter Metherall, Janet A McCormick, Roslyn J Simms & Albert C M Ong. (2022) Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response. Clinical Kidney Journal 15:6, pages 1160-1168.
Crossref
Crossref
Francesco Schettini, Navid Sobhani, Anna Ianza, Tiziana Triulzi, Alfredo Molteni, Maria Chiara Lazzari, Carla Strina, Manuela Milani, Silvia Paola Corona, Marianna Sirico, Ottavia Bernocchi, Fabiola Giudici, Maria Rosaria Cappelletti, Eva Ciruelos, Guy Jerusalem, Sherine Loi, Stephen B. Fox & Daniele Generali. (2020) Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study. Breast Cancer Research and Treatment 184:2, pages 421-431.
Crossref
Crossref
Karlton Wong, John Shen, Sarah D’Ambruoso, Dimitrios Stefanoudakis & Alexandra Drakaki. (2019) Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Metastatic Cancer Post Solid Organ Transplantation: A Case Report and Review of the Literature. Transplantation Proceedings 51:9, pages 3053-3058.
Crossref
Crossref
Bernard A. Zonnenberg, Maureen P. Neary, Mei Sheng Duh, Raluca Ionescu-Ittu, Jonathan Fortier & Francis Vekeman. (2018) Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus. PLOS ONE 13:11, pages e0204646.
Crossref
Crossref
Julio Pascual, Fritz Diekmann, Constantino Fernández-Rivera, Gonzalo Gómez-Marqués, Alex Gutiérrez-Dalmau, María José Pérez-Sáez, Asunción Sancho-Calabuig & Federico Oppenheimer. (2017) Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities. Nefrología (English Edition) 37:3, pages 253-266.
Crossref
Crossref
Julio Pascual, Fritz Diekmann, Constantino Fernández-Rivera, Gonzalo Gómez-Marqués, Alex Gutiérrez-Dalmau, María José Pérez-Sáez, Asunción Sancho-Calabuig & Federico Oppenheimer. (2017) Recomendaciones para el uso de everolimus en trasplante renal de novo: falsas creencias, mitos y realidades. Nefrología 37:3, pages 253-266.
Crossref
Crossref
Eric K. Rowinsky. 2016. mTOR Inhibition for Cancer Therapy: Past, Present and Future. mTOR Inhibition for Cancer Therapy: Past, Present and Future
1
17
.
James C Kuo, Nicole Gorddard & Robin Stuart-Harris. (2015) Renal failure requiring hemodialysis in two patients with metastatic breast cancer treated with everolimus. Breast Cancer Management 4:3, pages 129-134.
Crossref
Crossref
T. Santos, L. Santos, F. Macário, C. Romãozinho, R. Alves, M. Campos & A. Mota. (2015) New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients. Transplantation Proceedings 47:4, pages 906-910.
Crossref
Crossref
Denise A. Yardley. (2014) Adverse Event Management of mTOR Inhibitors During Treatment of Hormone Receptor–Positive Advanced Breast Cancer: Considerations for Oncologists. Clinical Breast Cancer 14:5, pages 297-308.
Crossref
Crossref
Eirini Savvidaki, Panagiotis Kazakopoulos, Evangelos Papachristou, Dimitrios Karavias, Vasilios Zavvos, Georgios Voliotis, Pantelitsa Kalliakmani, Markos Marangos & Dimitrios S. Goumenos. (2014) Replacement of Mycophenolate Acid With Everolimus in Patients Who Became Neutropenic After Renal Transplant. Experimental and Clinical Transplantation 12:1, pages 31-36.
Crossref
Crossref
S.M. Santos, C.M. Carlos, C.B. Cabanayan-Casasola & R.A. Danguilan. (2012) Everolimus with Reduced-dose Cyclosporine Versus Full-dose Cyclosporine and Mycophenolate in De Novo Renal Transplant Patients: A 2-Year Single-Center Experience. Transplantation Proceedings 44:1, pages 154-160.
Crossref
Crossref
P.A. Novoa, J.M. Grinyó, F.J.P. Ramos, P. Errasti, A. Franco, G. Aldana, J. Pefaur, A.M. Marti-Cuadros, A.B. Otero, N. Saval & F. Oppenheimer. (2011) De Novo Use of Everolimus With Elimination or Minimization of Cyclosporine in Renal Transplant Recipients. Transplantation Proceedings 43:9, pages 3331-3339.
Crossref
Crossref